BREXIT red tape is leading to the withdrawal of vital drugs from Northern Ireland due to the high costs for manufacturers, an industry chief has warned.

Firms already starting to withdraw vital drugs because of costly new red tape, says industry group.

Mother of son with severe epilepsy says ‘fight is not over’ as Brexit bans EU states fulfilling UK prescriptions

Eight-year-old Murray Gray, from Edinburgh, must fund £1,300 in cannabis oil shipments from Holland every month to battle life threatening epilepsy seizures

What has changed in the 31 days since the UK left and how has it impacted consumers and businesses?

From antibiotics to cancer drugs, The London Economic can reveal the full extent of the medicine supply crisis gripping Britain.

Supplies of prescribed medical cannabis set to run out in a matter of weeks, affecting up to 40 children.

DAN WHITE gives a personal account of how Brexit is already impacting the disabled.

Medical cannabis prescriptions can help reduce seizures in youngsters.

The parents of a six year old girl from Suffolk, with severe epilepsy, have run out of her medication, because of Brexit.

Supplies of life-saving Bedrolite oil, which is manufactured in the Netherlands, were set to run out in weeks.

Government gives two weeks notice that access to epilepsy treatment for nine-year-old Alfie Dingley will end

An inability to stockpile drugs for many serious illnesses mean shortages will hit patients hard, according to doctors. / Senior doctors have warned the NHS to brace itself for the “biggest threat it has ever faced” if the UK crashes out of the EU on October 31, as a leaked internal document reveals the risks to patients from expected drug shortages.

The mother of a boy with severe epilepsy has welcomed news that medical cannabis imports from the Netherlands can continue for a while longer.

About 40 severely epileptic children are affected because supply of medical cannabis is terminated

A report is warning the UK's medicine supply chain is "broken" with drug shortages becoming the "new normal" in Britain.

‘The medicines supply chain is broken at every level,’ warns Dr Leyla Hannbeck.

A report from the Nuffield Trust has concluded that the UK is facing “constantly elevated medicine shortages,” including some antibiotics and epilepsy drugs, which are being fuelled by Brexit.

Global issues are factor but experts say there are problems peculiar to Britain such as rising costs post-Brexit.

British pharmacists are struggling to get their hands on certain medicines for cancer, epilepsy, diabetes and menopause as drug supply issues intensify in the country.